AI assistant
Sending…
AEHR TEST SYSTEMS — Director's Dealing 2023
Jan 25, 2023
32300_dirs_2023-01-25_8f6acba8-1c3c-4a2e-9a98-54b773469eee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2023-01-23
Reporting Person: POSEDEL RHEA J (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-01-23 | Common Stock | S | 20000 | $32.9000 | Disposed | 543821 | Indirect |
| 2023-01-23 | Common Stock | S | 20000 | $34.9000 | Disposed | 523821 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 49018 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021.
F2: The amount reported includes shares subject to unvested restricted stock units.
F3: Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY 2022 of 143 shares on 11/18/2022. The closing price was $23.50 per share.
More from AEHR TEST SYSTEMS
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 4